论文信息 - Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide. - 字舞流文

Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide.

Tara B. Manion | A. Vaz | R. Robinson | Martha L Minich | D. Tess | Andrew G Swick | Peter Bertinato | M. Reese | J. Bartlett | Matthew R Reese | David A Tess | Ralph P Robinson | Jeremy A Bartlett | Andrew J Bessire | Judith Cosgrove | Patrick M Foley | Tara B Manion | Brenda Ramos | Theodore J Schmahai | Alfin Vaz | Angela Wolford | P. Bertinato | A. Bessire | Judith M Cosgrove | Patrick M. Foley | Martha L. Minich | Brenda Ramos | T. Schmahai | A. Swick | A. Wolford

[1] Spencer J. Williams,et al. Novel microsomal triglyceride transfer protein inhibitors , 2003 .

[2] T. Maurer,et al. RELATIONSHIP BETWEEN EXPOSURE AND NONSPECIFIC BINDING OF THIRTY-THREE CENTRAL NERVOUS SYSTEM DRUGS IN MICE , 2005, Drug Metabolism and Disposition.

[3] In vitro and in vivo profile of 5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid benzylmethyl carbamoylamide (dirlotapide), a novel potent MTP inhibitor for obesity. , 2007, Bioorganic & medicinal chemistry letters.

[4] J. Wren,et al. Dirlotapide: a review of its properties and role in the management of obesity in dogs. , 2007, Journal of veterinary pharmacology and therapeutics.

[5] G. Watts,et al. MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises? , 2007, Expert opinion on therapeutic targets.

[6] R. Hegele,et al. Microsomal triglyceride transfer protein inhibition–friend or foe? , 2008, Nature Clinical Practice Cardiovascular Medicine.

[7] David P. Carney,et al. Discovery of benzothiazole derivatives as efficacious and enterocyte-specific MTP inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[8] T. Hata,et al. Pharmacological Characterization of Diethyl-2-({3-dimethylcarbamoyl-4-[(4′-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein , 2011, Journal of Pharmacology and Experimental Therapeutics.